Biotech Clinical is a rules-based basket of 12 US-listed stocks — The top-rated US companies with the Biotech Clinical business model.. 42.8% backtested total return, -122.2% vs the S&P 500 since inception. Equal-weight, point-in-time, survivorship-corrected. Published for US investors. Not investment advice.
| Ticker | Company | Weight |
|---|---|---|
| ARWR | Arrowhead Pharmaceuticals, Inc. | 8.3% |
| HALO | Halozyme Therapeutics, Inc. | 8.3% |
| CPRX | Catalyst Pharmaceuticals, Inc. | 8.3% |
| EXEL | Exelixis, Inc. | 8.3% |
| BMRN | BioMarin Pharmaceutical Inc. | 8.3% |
| KRYS | Krystal Biotech, Inc. | 8.3% |
| ALNY | Alnylam Pharmaceuticals, Inc. | 8.3% |
| ELAN | Elanco Animal Health Incorporated | 8.3% |
| MDGL | Madrigal Pharmaceuticals, Inc. | 8.3% |
| AXSM | Axsome Therapeutics, Inc. | 8.3% |
| CYTK | Cytokinetics, Incorporated | 8.3% |
| IONS | Ionis Pharmaceuticals, Inc. | 8.3% |
Performance shown is backtested (hypothetical), not actual trades, benchmarked to the S&P 500 total return. Past performance does not guarantee future results. Signals is a publisher, not a broker or investment adviser. US users only.